Polymorphism of INS VNTR is associated with glutamic acid decarboxylase antibodies and postprandial C-peptide in patients with onset of diabetes after 35 years of age.
Variability in the number of tandem repeats of the insulin gene (INS VNTR) is probably involved in the genetic regulation of insulin secretion. The aim of this study was to investigate the association of INS VNTR polymorphism with the presence of glutamic acid decarboxylase antibodies (GADA) and C-peptide levels in patients with the onset of diabetes after 35 years of age. We investigated 117 patients, median of age 63 (range 40-83) years, median of diabetes duration 8 (range 1-30) years; 31 GADA-positive and 86 GADA-negative subjects. INS VNTR polymorphism was typed indirectly using - 23HphI (T/A) polymorphism, which is in complete linkage disequilibrium with INS VNTR. The I/I, I/III and III/III genotypes were found in 22 (71 %), 8 (26 %), 1 (3 %) GADA-positive individuals and in 39 (45 %), 35 (41 %), 12 (14 %) GADA-negative individuals, respectively. The Class I allele and the genotype I/I were significantly associated with the presence of GADA (OR=2.72, CI 95 %=1.29-5.73 and OR=2.95, CI 95 %=1.22-7.13). The presence of Class III allele was significantly associated with a higher level of postprandial C-peptide in GADA-positive subjects, even when regarding the duration of diabetes. Our results of INS VNTR polymorphism in patients with the onset of diabetes after 35 years of age confirm the association of Class I INS VNTR with autoimmune diabetes and the protective effect of Class III INS VNTR on the insulin secretion in GADA-positive subjects.
Matejková-Behanová
M
M
Institute of Endocrinology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Vanková
M
M
Hill
M
M
Kucera
P
P
Cinek
O
O
Andel
M
M
Bendlová
B
B
D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies / Q000097:blood; D002096:C-Peptide / Q000097:blood* / Q000378:metabolism; D016001:Confidence Intervals; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D003920:Diabetes Mellitus / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007328:Insulin / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D018598:Minisatellite Repeats / Q000235:genetics*; D016017:Odds Ratio; D018579:Patient Selection; D011110:Polymorphism, Genetic; D019518:Postprandial Period
D000906:Antibodies; D002096:C-Peptide; D007328:Insulin; D004247:DNA; D005968:Glutamate Decarboxylase